Silver Book Fact

A new study reports that using optogenetics, stimulating specific brain cells using light, may provide better results for Parkinson’s patients than traditional deep brain stimulation because of the ability to control different cells at specific times.

Gradinaru V, Mogri M, Thompson K, Henderson J, et al. Optical Deconstruction of Parkinsonian Neural Circuitry. Science. 2009; 324(5925): 354-9. http://www.ncbi.nlm.nih.gov/pubmed/19299587

Reference

Title
Optical Deconstruction of Parkinsonian Neural Circuitry
Publication
Science
Publication Date
2009
Authors
Gradinaru V, Mogri M, Thompson K, Henderson J, et al.
Volume & Issue
Volume 324, Issue 5925
Pages
354-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • A large set of NIH clinical trials are assessing interventions (including dietary supplements–creatine and coenzyme Q10) that may slow the progression of Parkinson’s disease.  
  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 Medicaid costs for people with the disease would be…  
  • It is imperative to weigh costs of implementing new technologies for predicting onset of Alzheimer’s disease through biomarkers and delaying onset earlier against the potential benefits of improving health. Overall…  
  • 2006 Medicines in Development for Neurologic Disorders